Figure 3. Multiply-budding yeast-like cells of Blastomyces helicus in calcofluor white stain of bronchoalveolar fluid ... Figure 3. Multiply-budding yeast-like.

Slides:



Advertisements
Similar presentations
Table 1 Patient characteristics of attendees of the influenza vaccination, irrespective of AF status From: Yield of screening for atrial fibrillation in.
Advertisements

From: Dynamic De/Centralization in Canada, 1867–2010
Figure 2. Chronic kidney disease risk tool application.
Figure 5: Three-dimensional reconstruction of the CT scan showing the trapped air in the head and neck region. From: Distinct subcutaneous emphysema following.
From: THE FALLACIES OF PATENT-HOLDUP THEORY
Fig. 1 Nodes in a conceptual knowledge graph
Figure 1: Pneumomediastinum and subcutaneous emphysema as indicated by the arrows. From: Pneumomediastinum and subcutaneous emphysema after successful.
From: Epidemiology of Inappropriate Empiric Antibiotic Therapy for Bacteremia Based on Discordant In vitro Susceptibilities: Risk factors and Taxon-level.
From: Detection of Bacteriuria by Canine Olfaction
Figure 3: Full-body skeletal scintigraphy.
Figure 1. The flow chart illustrates the construction process of anti-CRISPRdb, and the information that users can obtain from anti-CRISPRdb. From: Anti-CRISPRdb:
From: Herpes Zoster and Recurrent Herpes Zoster
Figure 1. Study population diagram
Figure 2 Mean pain intensity and pain relief over 12 hours of treatment (ITT population). *Difference from baseline (P 
Figure 3. Scatterplot of hue and colour saturation (chroma) for the five Aphelocoma unicolor subspecies. From: Cloudy with a chance of speciation: integrative.
Figure 1: Necrobiosis lipoidica: Yellow-brown skin lesions with indurated borders located on both lower legs. Figure 1: Necrobiosis lipoidica: Yellow-brown.
Figure 1. Circular taxonomy tree based on the species that were sequenced in our study. Unless provided in the caption above, the following copyright applies.
ADAb: anti-drug antibody.
FIGURE 1 Kidney biopsies of Patients 1 and 2
Figure 1 Hazard ratios as a function of annual mean PM2
Figure 1: Axial T2 W images of penis showed a well-defined septated area of 2 cm in the posterior aspect of ... Figure 1: Axial T2 W images.
FIGURE 1 Histological diagnoses divided into 8-year time frames (n = 1208). Unless provided in the caption above, the following copyright applies to the.
FIGURE 1 The effect of daprodustat on hemoglobin (Hgb) levels
FIGURE 2 Responses to the question: regarding vasoactive drugs, does your centre use the following frequently, rarely ... FIGURE 2 Responses to the question:
FIGURE 1 Maternal (A) urinary aldosterone; (B) plasma active renin; (C) urinary AGT concentrations; and (D) plasma AGT ... FIGURE 1 Maternal (A) urinary.
FIGURE 1 Flow chart of patient enrollment and exclusion
Fig. 1 Kaplan-Meier plot of cumulative incidence of cancer onset following dermatomyositis diagnosis stratified ... Anti-TIF1-Ab: anti-transcriptional.
Figure 1 Flortaucipir PET MUBADA/PERSI SUVr at baseline, 9 and 18 months for individual subjects. Each subject is ... Figure 1 Flortaucipir PET MUBADA/PERSI.
Fig. 1 Mean change from baseline in ANC ± s. e
Point estimates with ... Point estimates with 95% CI. HR: hip replacement; KR: knee replacement. Unless provided in the caption above, the following copyright.
FIGURE 1 Participant flow diagram. Exercise Counseling Clinic (ECC).
Graph 1. The number of homicide cases per year discussing neuro-evidence. Unless provided in the caption above, the following copyright applies to the.
Figure 1. Analysis of human TRIM5α protein with Blast-Search and PhyML+SMS ‘One click’ workflow. (A) NGPhylogeny.fr ... Figure 1. Analysis of human TRIM5α.
Figure 2. Natural history of chlamydia transmission, with arrows showing the transitions between health states. Figure 2. Natural history of chlamydia.
Figure 1 Nelson-Aalen estimates of the cumulative incidence rates for patients on versus off IST. ON = optic neuritis; ... Figure 1 Nelson-Aalen estimates.
FIGURE 1 Malta: a plate-style food guide
Figure 1. A, Crude incidence rates per 100 person-years of follow-up and 95% confidence intervals for each solid organ ... Figure 1. A, Crude incidence.
FIGURE 1 Study consort diagram
Fig. 2 Case 2. Levels of serum creatinine and anti-GBM antibodies before and during treatment with cyclophosphamide, ... Fig. 2 Case 2. Levels of serum.
FIGURE 1 Food groups consumed (mean, g/d) among US infants and young children by age group and tertile of mean ... FIGURE 1 Food groups consumed (mean,
Figure 1 Study flowchart and patient flow
Figure 4. Levels of cerebrospinal fluid (CSF) immune and inflammatory markers in participants grouped by CSF human ... Figure 4. Levels of cerebrospinal.
Figure 1. PaintOmics 3 workflow diagram
Figure 1. Schematic diagram of solar energy and coal-fired power generation system. Unless provided in the caption above, the following copyright applies.
Figure 1. Uncertainty reduction, value creation, and appropriation in two case studies. Unless provided in the caption above, the following copyright applies.
Figure 1 Ratio of the geometric mean concentration of hsTnT (A) and sST2 (B) at baseline (BL) and each subsequent ... Figure 1 Ratio of the geometric mean.
Figure 1. Time to clinical stability (a) and time to defervescence (b) in patients with pneumococcal pneumonia. ... Figure 1. Time to clinical stability.
Unless provided in the caption above, the following copyright applies to the content of this slide: Published by Oxford University Press on behalf of the.
Figure 1. MERMAID web server interface (Start page, Parameter page): MERMAID provides two ways to submit a protein ... Figure 1. MERMAID web server interface.
Figure 1. Yvis platform overview
Figure 1. The framework of NetGO with seven steps
Figure 1 Patient disposition
Figure 1 Diagram of patient and procedural follow-up for Cohorts A, B, and C. Cohort A: 6-month OCT and 12-month OCT, ... Figure 1 Diagram of patient and.
Figure 1. Trial profile. (A) Part A and (B) part B
Figure 1 Design of trials included in individual patient data meta-analysis. Unless provided in the caption above, the following copyright applies to the.
Figure 1 Distribution of WCD use days in WEARIT-II
Figure 1. Excess cost of methicillin-resistant Staphylococcus aureus (MRSA) compared with methicillin-susceptible S. ... Figure 1. Excess cost of methicillin-resistant.
Figure 1. The proportion of CSBM responders over the 2-week treatment period (A), the proportion of SBM responders by ... Figure 1. The proportion of CSBM.
Figure 1 Genetic results. No case had more than one diagnostic result
Figure 1. (A) Baseline contrast-enhanced CT scan of melanoma patient presenting with metastases in the liver and lymph ... Figure 1. (A) Baseline contrast-enhanced.
Figure 1. Prevalence of parasitic infection and anemia among the children. Unless provided in the caption above, the following copyright applies to the.
Source:Zimnisky (2014). Source:Zimnisky (2014).
Figure 1 Mechanisms of mitral regurgitation.
Fig. 2. Genetic differentiation among populations and individuals
Figure 1. Kaplan Meier curves showing crude product limit survival estimates and 95% confidence intervals for time to ... Figure 1. Kaplan Meier curves.
Figure 1. Unrooted phylogenetic trees for UL73 and UL74 based on amino acid sequences derived from 243 genome ... Figure 1. Unrooted phylogenetic trees.
Figure 1. (A) Overview of ENPD including data source, data processing and features. Transcriptomes from TSA, genomes ... Figure 1. (A) Overview of ENPD.
Figure 1. Hepatitis C screening and diagnostic algorithm at the MSF clinic, Karachi, Pakistan, March 2016–September ... Figure 1. Hepatitis C screening.
Figure 1. The C-Mill and the 7 C-Gait walking-adaptability tasks.
Figure 1. Enteropathogen prevalence in stool samples collected from 996 children in the Sanitation Hygiene Infant ... Figure 1. Enteropathogen prevalence.
Presentation transcript:

Figure 3. Multiply-budding yeast-like cells of Blastomyces helicus in calcofluor white stain of bronchoalveolar fluid ... Figure 3. Multiply-budding yeast-like cells of Blastomyces helicus in calcofluor white stain of bronchoalveolar fluid (A) and in gram stain of growth from a positive blood culture bottle (case h8) (B). Unless provided in the caption above, the following copyright applies to the content of this slide: © The Author(s) 2018. Published by Oxford University Press for the Infectious Diseases Society of America.This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com Clin Infect Dis, Volume 68, Issue 2, 07 June 2018, Pages 188–195, https://doi.org/10.1093/cid/ciy483 The content of this slide may be subject to copyright: please see the slide notes for details.

Figure 2. Chest radiography findings of 3 patients with pulmonary disease caused by Blastomyces helicus. A, Chest x-ray ... Figure 2. Chest radiography findings of 3 patients with pulmonary disease caused by Blastomyces helicus. A, Chest x-ray demonstrating diffuse nodules (case h8). B, Axial view of computed tomography (CT) of chest showing diffuse nodules and bilateral apical consolidation with cavitation (case h9). C, Axial view of CT of chest showing diffuse ground glass opacities, peribronchovascular nodules, and pleural effusions (case h5, from [15]). Unless provided in the caption above, the following copyright applies to the content of this slide: © The Author(s) 2018. Published by Oxford University Press for the Infectious Diseases Society of America.This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com Clin Infect Dis, Volume 68, Issue 2, 07 June 2018, Pages 188–195, https://doi.org/10.1093/cid/ciy483 The content of this slide may be subject to copyright: please see the slide notes for details.

Figure 4. (A-D) Morphological features of Blastomyces helicus in culture. A, Colonies showing mold to yeast transition ... Figure 4. (A-D) Morphological features of Blastomyces helicus in culture. A, Colonies showing mold to yeast transition on potato dextrose agar after 13 days at 35°C (case v1 isolate). B-C. Yeast-like phase at 35°C showing multiply-budding yeast-like cells proliferating in short branched chains (case h4 and h1 isolates, respectively). D, Mycelial phase at 25°C showing typical helically coiled hyphae and absence of conidia (case h2 isolate). Unless provided in the caption above, the following copyright applies to the content of this slide: © The Author(s) 2018. Published by Oxford University Press for the Infectious Diseases Society of America.This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com Clin Infect Dis, Volume 68, Issue 2, 07 June 2018, Pages 188–195, https://doi.org/10.1093/cid/ciy483 The content of this slide may be subject to copyright: please see the slide notes for details.

Figure 1. Geographic origins of human and veterinary Blastomyces helicus isolates, juxtaposed with areas classically ... Figure 1. Geographic origins of human and veterinary Blastomyces helicus isolates, juxtaposed with areas classically considered endemic for B. dermatitidis (modified from [17] based on [18–21]). Unless provided in the caption above, the following copyright applies to the content of this slide: © The Author(s) 2018. Published by Oxford University Press for the Infectious Diseases Society of America.This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com Clin Infect Dis, Volume 68, Issue 2, 07 June 2018, Pages 188–195, https://doi.org/10.1093/cid/ciy483 The content of this slide may be subject to copyright: please see the slide notes for details.